nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Gefitinib—lung cancer	0.0601	0.339	CbGbCtD
Treprostinil—CYP2C9—Teniposide—lung cancer	0.0582	0.329	CbGbCtD
Treprostinil—PTGIR—pulmonary artery—lung cancer	0.0467	0.436	CbGeAlD
Treprostinil—CYP2C9—Paclitaxel—lung cancer	0.0325	0.184	CbGbCtD
Treprostinil—CYP2C9—Cisplatin—lung cancer	0.0261	0.148	CbGbCtD
Treprostinil—PPARD—mammary gland—lung cancer	0.0154	0.143	CbGeAlD
Treprostinil—P2RY12—epithelium—lung cancer	0.0103	0.0961	CbGeAlD
Treprostinil—PTGIR—respiratory system—lung cancer	0.00786	0.0733	CbGeAlD
Treprostinil—PTGIR—epithelium—lung cancer	0.00657	0.0613	CbGeAlD
Treprostinil—PPARD—lung—lung cancer	0.00543	0.0507	CbGeAlD
Treprostinil—CYP2C9—mammary gland—lung cancer	0.00421	0.0393	CbGeAlD
Treprostinil—PTGIR—lung—lung cancer	0.00417	0.0389	CbGeAlD
Treprostinil—PPARD—lymph node—lung cancer	0.00372	0.0347	CbGeAlD
Treprostinil—PTGIR—lymph node—lung cancer	0.00285	0.0266	CbGeAlD
Treprostinil—Pruritus—Vinorelbine—lung cancer	0.000377	0.000813	CcSEcCtD
Treprostinil—Discomfort—Etoposide—lung cancer	0.000377	0.000812	CcSEcCtD
Treprostinil—Pain—Irinotecan—lung cancer	0.000376	0.00081	CcSEcCtD
Treprostinil—Arthralgia—Paclitaxel—lung cancer	0.000374	0.000806	CcSEcCtD
Treprostinil—Chest pain—Paclitaxel—lung cancer	0.000374	0.000806	CcSEcCtD
Treprostinil—Myalgia—Paclitaxel—lung cancer	0.000374	0.000806	CcSEcCtD
Treprostinil—Hypotension—Cisplatin—lung cancer	0.000373	0.000804	CcSEcCtD
Treprostinil—Anxiety—Paclitaxel—lung cancer	0.000373	0.000803	CcSEcCtD
Treprostinil—Erythema—Docetaxel—lung cancer	0.000372	0.000802	CcSEcCtD
Treprostinil—Decreased appetite—Gemcitabine—lung cancer	0.000372	0.000802	CcSEcCtD
Treprostinil—Nausea—Topotecan—lung cancer	0.00037	0.000798	CcSEcCtD
Treprostinil—Discomfort—Paclitaxel—lung cancer	0.000369	0.000796	CcSEcCtD
Treprostinil—Abdominal discomfort—Methotrexate—lung cancer	0.000369	0.000796	CcSEcCtD
Treprostinil—Fatigue—Gemcitabine—lung cancer	0.000369	0.000796	CcSEcCtD
Treprostinil—Pain—Gemcitabine—lung cancer	0.000366	0.000789	CcSEcCtD
Treprostinil—Nausea—Erlotinib—lung cancer	0.000366	0.000789	CcSEcCtD
Treprostinil—Diarrhoea—Vinorelbine—lung cancer	0.000365	0.000786	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000363	0.000784	CcSEcCtD
Treprostinil—Infection—Etoposide—lung cancer	0.000363	0.000783	CcSEcCtD
Treprostinil—Feeling abnormal—Irinotecan—lung cancer	0.000362	0.000781	CcSEcCtD
Treprostinil—Back pain—Docetaxel—lung cancer	0.00036	0.000776	CcSEcCtD
Treprostinil—Gastrointestinal pain—Irinotecan—lung cancer	0.000359	0.000775	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—lung cancer	0.000359	0.000773	CcSEcCtD
Treprostinil—Oedema—Paclitaxel—lung cancer	0.000358	0.000773	CcSEcCtD
Treprostinil—Paraesthesia—Cisplatin—lung cancer	0.000358	0.000772	CcSEcCtD
Treprostinil—Thrombocytopenia—Etoposide—lung cancer	0.000358	0.000771	CcSEcCtD
Treprostinil—Muscle spasms—Docetaxel—lung cancer	0.000358	0.000771	CcSEcCtD
Treprostinil—Tachycardia—Etoposide—lung cancer	0.000357	0.000769	CcSEcCtD
Treprostinil—Infection—Paclitaxel—lung cancer	0.000356	0.000768	CcSEcCtD
Treprostinil—Dyspnoea—Cisplatin—lung cancer	0.000356	0.000767	CcSEcCtD
Treprostinil—Feeling abnormal—Gemcitabine—lung cancer	0.000353	0.00076	CcSEcCtD
Treprostinil—Shock—Paclitaxel—lung cancer	0.000353	0.00076	CcSEcCtD
Treprostinil—Dizziness—Vinorelbine—lung cancer	0.000352	0.00076	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—lung cancer	0.000351	0.000757	CcSEcCtD
Treprostinil—Thrombocytopenia—Paclitaxel—lung cancer	0.000351	0.000756	CcSEcCtD
Treprostinil—Tachycardia—Paclitaxel—lung cancer	0.00035	0.000754	CcSEcCtD
Treprostinil—Anorexia—Etoposide—lung cancer	0.000348	0.000751	CcSEcCtD
Treprostinil—Abdominal pain—Irinotecan—lung cancer	0.000347	0.000749	CcSEcCtD
Treprostinil—Body temperature increased—Irinotecan—lung cancer	0.000347	0.000749	CcSEcCtD
Treprostinil—Decreased appetite—Cisplatin—lung cancer	0.000347	0.000748	CcSEcCtD
Treprostinil—Pneumonia—Methotrexate—lung cancer	0.000345	0.000744	CcSEcCtD
Treprostinil—Anaemia—Docetaxel—lung cancer	0.000344	0.000742	CcSEcCtD
Treprostinil—Depression—Methotrexate—lung cancer	0.000342	0.000738	CcSEcCtD
Treprostinil—Anorexia—Paclitaxel—lung cancer	0.000342	0.000736	CcSEcCtD
Treprostinil—Hypotension—Etoposide—lung cancer	0.000342	0.000736	CcSEcCtD
Treprostinil—Pain—Cisplatin—lung cancer	0.000341	0.000735	CcSEcCtD
Treprostinil—Vomiting—Vinorelbine—lung cancer	0.000339	0.00073	CcSEcCtD
Treprostinil—Body temperature increased—Gemcitabine—lung cancer	0.000338	0.000729	CcSEcCtD
Treprostinil—Rash—Vinorelbine—lung cancer	0.000336	0.000724	CcSEcCtD
Treprostinil—Dermatitis—Vinorelbine—lung cancer	0.000336	0.000724	CcSEcCtD
Treprostinil—Hypotension—Paclitaxel—lung cancer	0.000335	0.000722	CcSEcCtD
Treprostinil—Headache—Vinorelbine—lung cancer	0.000334	0.00072	CcSEcCtD
Treprostinil—Syncope—Docetaxel—lung cancer	0.000334	0.00072	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—lung cancer	0.000333	0.000719	CcSEcCtD
Treprostinil—Palpitations—Docetaxel—lung cancer	0.000329	0.000709	CcSEcCtD
Treprostinil—Feeling abnormal—Cisplatin—lung cancer	0.000329	0.000709	CcSEcCtD
Treprostinil—Paraesthesia—Etoposide—lung cancer	0.000328	0.000708	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—lung cancer	0.000327	0.000706	CcSEcCtD
Treprostinil—Loss of consciousness—Docetaxel—lung cancer	0.000327	0.000705	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000327	0.000704	CcSEcCtD
Treprostinil—Dyspnoea—Etoposide—lung cancer	0.000326	0.000702	CcSEcCtD
Treprostinil—Cough—Docetaxel—lung cancer	0.000325	0.0007	CcSEcCtD
Treprostinil—Insomnia—Paclitaxel—lung cancer	0.000324	0.000699	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—lung cancer	0.000324	0.000698	CcSEcCtD
Treprostinil—Paraesthesia—Paclitaxel—lung cancer	0.000322	0.000694	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—lung cancer	0.000321	0.000691	CcSEcCtD
Treprostinil—Dyspnoea—Paclitaxel—lung cancer	0.00032	0.000689	CcSEcCtD
Treprostinil—Decreased appetite—Etoposide—lung cancer	0.000318	0.000685	CcSEcCtD
Treprostinil—Myalgia—Docetaxel—lung cancer	0.000317	0.000683	CcSEcCtD
Treprostinil—Arthralgia—Docetaxel—lung cancer	0.000317	0.000683	CcSEcCtD
Treprostinil—Chest pain—Docetaxel—lung cancer	0.000317	0.000683	CcSEcCtD
Treprostinil—Nausea—Vinorelbine—lung cancer	0.000316	0.000682	CcSEcCtD
Treprostinil—Dyspepsia—Paclitaxel—lung cancer	0.000315	0.00068	CcSEcCtD
Treprostinil—Body temperature increased—Cisplatin—lung cancer	0.000315	0.00068	CcSEcCtD
Treprostinil—Asthenia—Irinotecan—lung cancer	0.000315	0.00068	CcSEcCtD
Treprostinil—Fatigue—Etoposide—lung cancer	0.000315	0.000679	CcSEcCtD
Treprostinil—Pain—Etoposide—lung cancer	0.000313	0.000674	CcSEcCtD
Treprostinil—Decreased appetite—Paclitaxel—lung cancer	0.000312	0.000672	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—lung cancer	0.00031	0.000668	CcSEcCtD
Treprostinil—Fatigue—Paclitaxel—lung cancer	0.000309	0.000666	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—lung cancer	0.000308	0.000664	CcSEcCtD
Treprostinil—Asthenia—Gemcitabine—lung cancer	0.000307	0.000662	CcSEcCtD
Treprostinil—Pain—Paclitaxel—lung cancer	0.000306	0.000661	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—lung cancer	0.000306	0.000659	CcSEcCtD
Treprostinil—Oedema—Docetaxel—lung cancer	0.000304	0.000655	CcSEcCtD
Treprostinil—Pruritus—Gemcitabine—lung cancer	0.000303	0.000653	CcSEcCtD
Treprostinil—Infection—Docetaxel—lung cancer	0.000302	0.000651	CcSEcCtD
Treprostinil—Feeling abnormal—Etoposide—lung cancer	0.000301	0.000649	CcSEcCtD
Treprostinil—Diarrhoea—Irinotecan—lung cancer	0.000301	0.000648	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—lung cancer	0.000299	0.000644	CcSEcCtD
Treprostinil—Gastrointestinal pain—Etoposide—lung cancer	0.000299	0.000644	CcSEcCtD
Treprostinil—Shock—Docetaxel—lung cancer	0.000299	0.000644	CcSEcCtD
Treprostinil—Thrombocytopenia—Docetaxel—lung cancer	0.000297	0.000641	CcSEcCtD
Treprostinil—Tachycardia—Docetaxel—lung cancer	0.000296	0.000639	CcSEcCtD
Treprostinil—Feeling abnormal—Paclitaxel—lung cancer	0.000295	0.000637	CcSEcCtD
Treprostinil—Gastrointestinal pain—Paclitaxel—lung cancer	0.000293	0.000632	CcSEcCtD
Treprostinil—Diarrhoea—Gemcitabine—lung cancer	0.000293	0.000631	CcSEcCtD
Treprostinil—Dizziness—Irinotecan—lung cancer	0.000291	0.000626	CcSEcCtD
Treprostinil—Anorexia—Docetaxel—lung cancer	0.00029	0.000624	CcSEcCtD
Treprostinil—Abdominal pain—Etoposide—lung cancer	0.000289	0.000623	CcSEcCtD
Treprostinil—Body temperature increased—Etoposide—lung cancer	0.000289	0.000623	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—lung cancer	0.000289	0.000623	CcSEcCtD
Treprostinil—Asthenia—Cisplatin—lung cancer	0.000286	0.000617	CcSEcCtD
Treprostinil—Hypotension—Docetaxel—lung cancer	0.000284	0.000612	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—lung cancer	0.000283	0.000611	CcSEcCtD
Treprostinil—Abdominal pain—Paclitaxel—lung cancer	0.000283	0.000611	CcSEcCtD
Treprostinil—Body temperature increased—Paclitaxel—lung cancer	0.000283	0.000611	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—lung cancer	0.00028	0.000604	CcSEcCtD
Treprostinil—Vomiting—Irinotecan—lung cancer	0.000279	0.000602	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—lung cancer	0.000279	0.000601	CcSEcCtD
Treprostinil—Rash—Irinotecan—lung cancer	0.000277	0.000597	CcSEcCtD
Treprostinil—Dermatitis—Irinotecan—lung cancer	0.000277	0.000597	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000277	0.000597	CcSEcCtD
Treprostinil—Headache—Irinotecan—lung cancer	0.000275	0.000593	CcSEcCtD
Treprostinil—Insomnia—Docetaxel—lung cancer	0.000275	0.000592	CcSEcCtD
Treprostinil—Diarrhoea—Cisplatin—lung cancer	0.000273	0.000588	CcSEcCtD
Treprostinil—Paraesthesia—Docetaxel—lung cancer	0.000273	0.000588	CcSEcCtD
Treprostinil—Vomiting—Gemcitabine—lung cancer	0.000272	0.000587	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—lung cancer	0.000272	0.000586	CcSEcCtD
Treprostinil—Dyspnoea—Docetaxel—lung cancer	0.000271	0.000584	CcSEcCtD
Treprostinil—Rash—Gemcitabine—lung cancer	0.00027	0.000582	CcSEcCtD
Treprostinil—Dermatitis—Gemcitabine—lung cancer	0.00027	0.000581	CcSEcCtD
Treprostinil—Erythema—Methotrexate—lung cancer	0.000268	0.000578	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—lung cancer	0.000268	0.000578	CcSEcCtD
Treprostinil—Headache—Gemcitabine—lung cancer	0.000268	0.000578	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—lung cancer	0.000268	0.000577	CcSEcCtD
Treprostinil—Dyspepsia—Docetaxel—lung cancer	0.000267	0.000576	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—lung cancer	0.000267	0.000575	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—lung cancer	0.000265	0.000571	CcSEcCtD
Treprostinil—Decreased appetite—Docetaxel—lung cancer	0.000264	0.000569	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—lung cancer	0.000263	0.000567	CcSEcCtD
Treprostinil—Asthenia—Etoposide—lung cancer	0.000262	0.000565	CcSEcCtD
Treprostinil—Fatigue—Docetaxel—lung cancer	0.000262	0.000565	CcSEcCtD
Treprostinil—Nausea—Irinotecan—lung cancer	0.000261	0.000563	CcSEcCtD
Treprostinil—Pain—Docetaxel—lung cancer	0.00026	0.00056	CcSEcCtD
Treprostinil—Back pain—Methotrexate—lung cancer	0.000259	0.000559	CcSEcCtD
Treprostinil—Pruritus—Etoposide—lung cancer	0.000259	0.000557	CcSEcCtD
Treprostinil—Asthenia—Paclitaxel—lung cancer	0.000257	0.000554	CcSEcCtD
Treprostinil—Nausea—Gemcitabine—lung cancer	0.000254	0.000548	CcSEcCtD
Treprostinil—Vomiting—Cisplatin—lung cancer	0.000254	0.000547	CcSEcCtD
Treprostinil—Pruritus—Paclitaxel—lung cancer	0.000254	0.000547	CcSEcCtD
Treprostinil—Rash—Cisplatin—lung cancer	0.000252	0.000542	CcSEcCtD
Treprostinil—Dermatitis—Cisplatin—lung cancer	0.000251	0.000542	CcSEcCtD
Treprostinil—Feeling abnormal—Docetaxel—lung cancer	0.00025	0.00054	CcSEcCtD
Treprostinil—Diarrhoea—Etoposide—lung cancer	0.00025	0.000539	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—lung cancer	0.000249	0.000537	CcSEcCtD
Treprostinil—Gastrointestinal pain—Docetaxel—lung cancer	0.000248	0.000535	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—lung cancer	0.000248	0.000534	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—lung cancer	0.000248	0.000534	CcSEcCtD
Treprostinil—Diarrhoea—Paclitaxel—lung cancer	0.000245	0.000529	CcSEcCtD
Treprostinil—Malaise—Methotrexate—lung cancer	0.000242	0.000521	CcSEcCtD
Treprostinil—Dizziness—Etoposide—lung cancer	0.000242	0.000521	CcSEcCtD
Treprostinil—Body temperature increased—Docetaxel—lung cancer	0.00024	0.000518	CcSEcCtD
Treprostinil—Abdominal pain—Docetaxel—lung cancer	0.00024	0.000518	CcSEcCtD
Treprostinil—Dizziness—Paclitaxel—lung cancer	0.000237	0.000511	CcSEcCtD
Treprostinil—Nausea—Cisplatin—lung cancer	0.000237	0.000511	CcSEcCtD
Treprostinil—Cough—Methotrexate—lung cancer	0.000234	0.000505	CcSEcCtD
Treprostinil—Vomiting—Etoposide—lung cancer	0.000232	0.000501	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—lung cancer	0.000232	0.000501	CcSEcCtD
Treprostinil—Rash—Etoposide—lung cancer	0.00023	0.000497	CcSEcCtD
Treprostinil—Dermatitis—Etoposide—lung cancer	0.00023	0.000496	CcSEcCtD
Treprostinil—Headache—Etoposide—lung cancer	0.000229	0.000494	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—lung cancer	0.000228	0.000492	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—lung cancer	0.000228	0.000492	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—lung cancer	0.000228	0.000492	CcSEcCtD
Treprostinil—Tension—Doxorubicin—lung cancer	0.000228	0.000491	CcSEcCtD
Treprostinil—Vomiting—Paclitaxel—lung cancer	0.000228	0.000491	CcSEcCtD
Treprostinil—Rash—Paclitaxel—lung cancer	0.000226	0.000487	CcSEcCtD
Treprostinil—Dermatitis—Paclitaxel—lung cancer	0.000226	0.000487	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—lung cancer	0.000226	0.000486	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—lung cancer	0.000226	0.000486	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—lung cancer	0.000225	0.000484	CcSEcCtD
Treprostinil—Headache—Paclitaxel—lung cancer	0.000225	0.000484	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—lung cancer	0.000223	0.000481	CcSEcCtD
Treprostinil—Asthenia—Docetaxel—lung cancer	0.000218	0.00047	CcSEcCtD
Treprostinil—Infection—Methotrexate—lung cancer	0.000218	0.000469	CcSEcCtD
Treprostinil—Nausea—Etoposide—lung cancer	0.000217	0.000468	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—lung cancer	0.000216	0.000465	CcSEcCtD
Treprostinil—Pruritus—Docetaxel—lung cancer	0.000215	0.000463	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—lung cancer	0.000215	0.000463	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—lung cancer	0.000214	0.000462	CcSEcCtD
Treprostinil—Nausea—Paclitaxel—lung cancer	0.000213	0.000459	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—lung cancer	0.000209	0.000452	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—lung cancer	0.000209	0.00045	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—lung cancer	0.000208	0.000449	CcSEcCtD
Treprostinil—Diarrhoea—Docetaxel—lung cancer	0.000208	0.000448	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—lung cancer	0.000205	0.000443	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—lung cancer	0.000205	0.000441	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—lung cancer	0.000204	0.00044	CcSEcCtD
Treprostinil—Cough—Doxorubicin—lung cancer	0.000203	0.000437	CcSEcCtD
Treprostinil—Dizziness—Docetaxel—lung cancer	0.000201	0.000433	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000199	0.00043	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—lung cancer	0.000198	0.000427	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—lung cancer	0.000198	0.000426	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—lung cancer	0.000198	0.000426	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—lung cancer	0.000198	0.000426	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—lung cancer	0.000197	0.000425	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—lung cancer	0.000197	0.000424	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—lung cancer	0.000195	0.000421	CcSEcCtD
Treprostinil—Dyspnoea—Methotrexate—lung cancer	0.000195	0.000421	CcSEcCtD
Treprostinil—Vomiting—Docetaxel—lung cancer	0.000193	0.000416	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—lung cancer	0.000193	0.000415	CcSEcCtD
Treprostinil—Rash—Docetaxel—lung cancer	0.000192	0.000413	CcSEcCtD
Treprostinil—Dermatitis—Docetaxel—lung cancer	0.000191	0.000412	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—lung cancer	0.00019	0.00041	CcSEcCtD
Treprostinil—Headache—Docetaxel—lung cancer	0.00019	0.00041	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—lung cancer	0.00019	0.000409	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—lung cancer	0.000189	0.000407	CcSEcCtD
Treprostinil—Infection—Doxorubicin—lung cancer	0.000188	0.000406	CcSEcCtD
Treprostinil—Pain—Methotrexate—lung cancer	0.000187	0.000404	CcSEcCtD
Treprostinil—Shock—Doxorubicin—lung cancer	0.000187	0.000402	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—lung cancer	0.000186	0.0004	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—lung cancer	0.000185	0.000399	CcSEcCtD
Treprostinil—Anorexia—Doxorubicin—lung cancer	0.000181	0.00039	CcSEcCtD
Treprostinil—Nausea—Docetaxel—lung cancer	0.00018	0.000389	CcSEcCtD
Treprostinil—Feeling abnormal—Methotrexate—lung cancer	0.00018	0.000389	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—lung cancer	0.000179	0.000386	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—lung cancer	0.000177	0.000382	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—lung cancer	0.000173	0.000373	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—lung cancer	0.000173	0.000373	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000173	0.000372	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—lung cancer	0.000171	0.00037	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—lung cancer	0.00017	0.000367	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—lung cancer	0.000169	0.000364	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—lung cancer	0.000167	0.00036	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—lung cancer	0.000165	0.000355	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—lung cancer	0.000163	0.000352	CcSEcCtD
Treprostinil—Pain—Doxorubicin—lung cancer	0.000162	0.000349	CcSEcCtD
Treprostinil—Asthenia—Methotrexate—lung cancer	0.000157	0.000339	CcSEcCtD
Treprostinil—Feeling abnormal—Doxorubicin—lung cancer	0.000156	0.000337	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—lung cancer	0.000155	0.000334	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—lung cancer	0.000155	0.000334	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—lung cancer	0.00015	0.000323	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—lung cancer	0.00015	0.000323	CcSEcCtD
Treprostinil—Diarrhoea—Methotrexate—lung cancer	0.00015	0.000323	CcSEcCtD
Treprostinil—Dizziness—Methotrexate—lung cancer	0.000145	0.000312	CcSEcCtD
Treprostinil—Vomiting—Methotrexate—lung cancer	0.000139	0.0003	CcSEcCtD
Treprostinil—Rash—Methotrexate—lung cancer	0.000138	0.000298	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—lung cancer	0.000138	0.000297	CcSEcCtD
Treprostinil—Headache—Methotrexate—lung cancer	0.000137	0.000296	CcSEcCtD
Treprostinil—Asthenia—Doxorubicin—lung cancer	0.000136	0.000293	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—lung cancer	0.000134	0.000289	CcSEcCtD
Treprostinil—Nausea—Methotrexate—lung cancer	0.00013	0.00028	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—lung cancer	0.00013	0.00028	CcSEcCtD
Treprostinil—Dizziness—Doxorubicin—lung cancer	0.000125	0.00027	CcSEcCtD
Treprostinil—Vomiting—Doxorubicin—lung cancer	0.000121	0.00026	CcSEcCtD
Treprostinil—Rash—Doxorubicin—lung cancer	0.00012	0.000258	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—lung cancer	0.000119	0.000257	CcSEcCtD
Treprostinil—Headache—Doxorubicin—lung cancer	0.000119	0.000256	CcSEcCtD
Treprostinil—Nausea—Doxorubicin—lung cancer	0.000113	0.000243	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—SRC—lung cancer	0.000102	0.000405	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TYMS—lung cancer	0.000101	0.0004	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CD—lung cancer	0.0001	0.000398	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—POMC—lung cancer	0.0001	0.000397	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—lung cancer	9.97e-05	0.000396	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—lung cancer	9.95e-05	0.000395	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—POMC—lung cancer	9.87e-05	0.000392	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUNB—lung cancer	9.83e-05	0.00039	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NRAS—lung cancer	9.82e-05	0.00039	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COL4A3BP—lung cancer	9.77e-05	0.000388	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AZIN2—lung cancer	9.77e-05	0.000388	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STK11—lung cancer	9.7e-05	0.000385	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6R—lung cancer	9.63e-05	0.000382	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CG—lung cancer	9.54e-05	0.000379	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1A1—lung cancer	9.45e-05	0.000375	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK3—lung cancer	9.41e-05	0.000373	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ERCC2—lung cancer	9.37e-05	0.000372	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FOXO3—lung cancer	9.36e-05	0.000372	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CD—lung cancer	9.24e-05	0.000367	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—lung cancer	9.19e-05	0.000365	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAP2K1—lung cancer	9.18e-05	0.000364	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CD—lung cancer	9.12e-05	0.000362	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	9.11e-05	0.000362	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—POMC—lung cancer	9.08e-05	0.000361	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STK11—lung cancer	8.93e-05	0.000354	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6R—lung cancer	8.86e-05	0.000352	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—CREBBP—lung cancer	8.83e-05	0.00035	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	8.83e-05	0.00035	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AVP—lung cancer	8.77e-05	0.000348	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CB—lung cancer	8.75e-05	0.000347	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FOXO3—lung cancer	8.62e-05	0.000342	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—lung cancer	8.45e-05	0.000336	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1R—lung cancer	8.45e-05	0.000335	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAP2K1—lung cancer	8.45e-05	0.000335	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—lung cancer	8.44e-05	0.000335	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—lung cancer	8.41e-05	0.000334	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CD—lung cancer	8.39e-05	0.000333	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ATP5H—lung cancer	8.31e-05	0.00033	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HES1—lung cancer	8.3e-05	0.000329	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—lung cancer	8.29e-05	0.000329	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—lung cancer	8.17e-05	0.000324	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RAF1—lung cancer	8.14e-05	0.000323	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOA1—lung cancer	8.11e-05	0.000322	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AVP—lung cancer	8.08e-05	0.000321	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CB—lung cancer	8.05e-05	0.00032	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—lung cancer	8.04e-05	0.000319	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CB—lung cancer	7.95e-05	0.000315	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—lung cancer	7.81e-05	0.00031	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1R—lung cancer	7.77e-05	0.000309	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—lung cancer	7.77e-05	0.000308	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.76e-05	0.000308	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—lung cancer	7.74e-05	0.000307	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	7.64e-05	0.000303	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HES1—lung cancer	7.64e-05	0.000303	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—lung cancer	7.64e-05	0.000303	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB3—lung cancer	7.59e-05	0.000301	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—lung cancer	7.51e-05	0.000298	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RAF1—lung cancer	7.49e-05	0.000297	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLBD1—lung cancer	7.41e-05	0.000294	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—lung cancer	7.4e-05	0.000294	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—lung cancer	7.4e-05	0.000294	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CB—lung cancer	7.31e-05	0.00029	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—lung cancer	7.3e-05	0.00029	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	7.29e-05	0.000289	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TERT—lung cancer	7.27e-05	0.000289	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—lung cancer	7.19e-05	0.000285	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGFR1—lung cancer	7.06e-05	0.00028	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—lung cancer	7.05e-05	0.00028	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—lung cancer	7.03e-05	0.000279	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB3—lung cancer	6.98e-05	0.000277	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HIF1A—lung cancer	6.95e-05	0.000276	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—lung cancer	6.9e-05	0.000274	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CREBBP—lung cancer	6.86e-05	0.000272	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD17B10—lung cancer	6.78e-05	0.000269	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—lung cancer	6.72e-05	0.000267	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOA1—lung cancer	6.71e-05	0.000266	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TERT—lung cancer	6.69e-05	0.000266	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—lung cancer	6.65e-05	0.000264	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CD—lung cancer	6.51e-05	0.000258	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGFR1—lung cancer	6.5e-05	0.000258	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—lung cancer	6.42e-05	0.000255	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HIF1A—lung cancer	6.4e-05	0.000254	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—lung cancer	6.35e-05	0.000252	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CKB—lung cancer	6.3e-05	0.00025	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOA1—lung cancer	6.18e-05	0.000245	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APC—lung cancer	6.13e-05	0.000243	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—lung cancer	6.13e-05	0.000243	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIT—lung cancer	6.13e-05	0.000243	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NRAS—lung cancer	6.13e-05	0.000243	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—lung cancer	6.12e-05	0.000243	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGF—lung cancer	6.06e-05	0.00024	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM2—lung cancer	5.92e-05	0.000235	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CNDP2—lung cancer	5.92e-05	0.000235	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK3—lung cancer	5.87e-05	0.000233	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—lung cancer	5.83e-05	0.000231	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTMR3—lung cancer	5.76e-05	0.000229	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BRAF—lung cancer	5.76e-05	0.000229	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6R—lung cancer	5.69e-05	0.000226	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CREBBP—lung cancer	5.68e-05	0.000225	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CB—lung cancer	5.67e-05	0.000225	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIT—lung cancer	5.64e-05	0.000224	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—lung cancer	5.64e-05	0.000224	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APC—lung cancer	5.64e-05	0.000224	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NRAS—lung cancer	5.64e-05	0.000224	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—lung cancer	5.62e-05	0.000223	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PGAM1—lung cancer	5.61e-05	0.000223	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—lung cancer	5.58e-05	0.000222	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGF—lung cancer	5.57e-05	0.000221	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAP2K1—lung cancer	5.42e-05	0.000215	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK3—lung cancer	5.4e-05	0.000214	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK3—lung cancer	5.39e-05	0.000214	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CD—lung cancer	5.39e-05	0.000214	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—lung cancer	5.37e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2A7—lung cancer	5.36e-05	0.000213	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—lung cancer	5.33e-05	0.000212	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BRAF—lung cancer	5.3e-05	0.00021	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—lung cancer	5.27e-05	0.000209	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDC4—lung cancer	5.24e-05	0.000208	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—lung cancer	5.24e-05	0.000208	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6R—lung cancer	5.23e-05	0.000208	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CREBBP—lung cancer	5.23e-05	0.000207	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—lung cancer	5.14e-05	0.000204	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAP2K1—lung cancer	4.99e-05	0.000198	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CD—lung cancer	4.96e-05	0.000197	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—lung cancer	4.91e-05	0.000195	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTEN—lung cancer	4.9e-05	0.000195	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—lung cancer	4.85e-05	0.000193	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—lung cancer	4.84e-05	0.000192	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MDM2—lung cancer	4.82e-05	0.000191	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAF1—lung cancer	4.81e-05	0.000191	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RRM1—lung cancer	4.77e-05	0.000189	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA3—lung cancer	4.77e-05	0.000189	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB2—lung cancer	4.76e-05	0.000189	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CB—lung cancer	4.69e-05	0.000186	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTOR—lung cancer	4.69e-05	0.000186	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—EP300—lung cancer	4.67e-05	0.000186	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—lung cancer	4.51e-05	0.000179	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—B4GALT5—lung cancer	4.49e-05	0.000178	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—lung cancer	4.48e-05	0.000178	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—lung cancer	4.46e-05	0.000177	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MDM2—lung cancer	4.44e-05	0.000176	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RAF1—lung cancer	4.42e-05	0.000176	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB2—lung cancer	4.38e-05	0.000174	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA4—lung cancer	4.37e-05	0.000173	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—lung cancer	4.36e-05	0.000173	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CB—lung cancer	4.32e-05	0.000171	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTOR—lung cancer	4.32e-05	0.000171	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—lung cancer	4.32e-05	0.000171	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—lung cancer	4.31e-05	0.000171	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—lung cancer	4.29e-05	0.00017	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.27e-05	0.000169	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA2—lung cancer	4.25e-05	0.000169	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—lung cancer	4.2e-05	0.000167	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—lung cancer	4.19e-05	0.000166	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—lung cancer	4.15e-05	0.000165	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—lung cancer	4.12e-05	0.000164	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA1—lung cancer	4.1e-05	0.000163	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—lung cancer	4.08e-05	0.000162	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1A—lung cancer	4.07e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCC3—lung cancer	4.06e-05	0.000161	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTEN—lung cancer	4.06e-05	0.000161	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—lung cancer	4.01e-05	0.000159	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—lung cancer	3.97e-05	0.000158	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—lung cancer	3.97e-05	0.000157	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—lung cancer	3.96e-05	0.000157	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—lung cancer	3.95e-05	0.000157	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKR1C1—lung cancer	3.93e-05	0.000156	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EP300—lung cancer	3.87e-05	0.000154	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—lung cancer	3.87e-05	0.000154	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—lung cancer	3.86e-05	0.000153	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UGT1A1—lung cancer	3.82e-05	0.000151	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SRC—lung cancer	3.76e-05	0.000149	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—lung cancer	3.75e-05	0.000149	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1A—lung cancer	3.74e-05	0.000149	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTEN—lung cancer	3.73e-05	0.000148	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNG11—lung cancer	3.68e-05	0.000146	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—lung cancer	3.66e-05	0.000145	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.66e-05	0.000145	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—lung cancer	3.64e-05	0.000145	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—lung cancer	3.63e-05	0.000144	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—lung cancer	3.63e-05	0.000144	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRAS—lung cancer	3.62e-05	0.000144	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EP300—lung cancer	3.56e-05	0.000141	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDOA—lung cancer	3.5e-05	0.000139	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK3—lung cancer	3.47e-05	0.000138	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SRC—lung cancer	3.46e-05	0.000137	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—lung cancer	3.46e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NCOA3—lung cancer	3.4e-05	0.000135	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—lung cancer	3.37e-05	0.000134	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—lung cancer	3.37e-05	0.000134	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.34e-05	0.000133	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—lung cancer	3.34e-05	0.000133	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRAS—lung cancer	3.33e-05	0.000132	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCG2—lung cancer	3.31e-05	0.000131	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADCY1—lung cancer	3.31e-05	0.000131	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—lung cancer	3.3e-05	0.000131	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HPGDS—lung cancer	3.24e-05	0.000129	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO2—lung cancer	3.24e-05	0.000129	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP2R1B—lung cancer	3.22e-05	0.000128	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK3—lung cancer	3.19e-05	0.000127	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.18e-05	0.000126	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTT1—lung cancer	3.15e-05	0.000125	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—lung cancer	3.11e-05	0.000124	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCLC—lung cancer	3.11e-05	0.000123	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2A6—lung cancer	3.11e-05	0.000123	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—lung cancer	3.1e-05	0.000123	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.1e-05	0.000123	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—lung cancer	3.03e-05	0.00012	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO1—lung cancer	2.95e-05	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.94e-05	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.9e-05	0.000115	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—lung cancer	2.87e-05	0.000114	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—lung cancer	2.86e-05	0.000114	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—lung cancer	2.82e-05	0.000112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—lung cancer	2.77e-05	0.00011	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—lung cancer	2.65e-05	0.000105	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2E1—lung cancer	2.65e-05	0.000105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—lung cancer	2.63e-05	0.000105	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NQO1—lung cancer	2.62e-05	0.000104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.56e-05	0.000102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—lung cancer	2.55e-05	0.000101	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.54e-05	0.000101	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—lung cancer	2.53e-05	0.000101	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—lung cancer	2.44e-05	9.67e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—STK11—lung cancer	2.36e-05	9.36e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—lung cancer	2.34e-05	9.28e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—lung cancer	2.33e-05	9.26e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.21e-05	8.78e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—lung cancer	2.18e-05	8.66e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—lung cancer	2.15e-05	8.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAT—lung cancer	2.12e-05	8.43e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.11e-05	8.38e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—lung cancer	2.06e-05	8.2e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TYMS—lung cancer	2.03e-05	8.05e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—lung cancer	2e-05	7.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1A1—lung cancer	1.9e-05	7.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ERCC2—lung cancer	1.88e-05	7.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA1—lung cancer	1.63e-05	6.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.56e-05	6.2e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—lung cancer	1.49e-05	5.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—lung cancer	1.42e-05	5.62e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CREBBP—lung cancer	1.38e-05	5.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CD—lung cancer	1.31e-05	5.19e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—lung cancer	1.29e-05	5.13e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CB—lung cancer	1.14e-05	4.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—lung cancer	1.13e-05	4.49e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTEN—lung cancer	9.86e-06	3.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—EP300—lung cancer	9.4e-06	3.73e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—lung cancer	6.95e-06	2.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—lung cancer	5.68e-06	2.25e-05	CbGpPWpGaD
